...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
【24h】

Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.

机译:在白色念珠菌中,临床上显着的米卡芬净抗药性涉及对葡聚糖合酶催化亚基GSC1(FKS1)等位基因的修饰,然后丧失杂合性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine the mechanism of intermediate- and high-level echinocandin resistance, resulting from heterozygous and homozygous mutations in GSC1 (FKS1), in both laboratory-generated and clinical isolates of Candida albicans. METHODS: The DNA sequences of the entire open reading frames of GSC1, GSL1 (FKS3) and RHO1, which may contribute to the beta-1,3-glucan synthase of a micafungin-susceptible strain and a resistant clinical isolate, were compared. A spontaneous heterozygous mutant isolated by selection for micafungin resistance, and a panel of laboratory-generated homozygous and heterozygous mutants that possessed combinations of the echinocandin-susceptible and -resistant alleles, or mutants with individual GSC1 alleles deleted, were used to compare levels of echinocandin resistance and inhibition of glucan synthase activity. RESULTS: DNA sequence analysis identified a mutation, S645P, in both alleles of GSC1 from the clinical isolate. GSL1 had two homozygous amino acid changes and five non-synonymous nucleotide polymorphisms due to allelic variation. The predicted amino acid sequence of Rho1p was conserved between strains. Reconstruction of the heterozygous (S645/S645F) and homozygous (S645F/S645F) mutation showed that the homozygous mutation conferred a higher level of micafungin resistance (4 mg/L) than the heterozygous mutation (1 mg/L). Exposure of the heterozygous mutant to micafungin resulted in a loss of heterozygosity. Kinetic analysis of beta-1,3-glucan synthase activity showed that the homozygous and heterozygous mutations gave echinocandin susceptibility profiles that correlated with their MIC values. CONCLUSIONS: A homozygous hot-spot mutation in GSC1, caused by mutation in one allele and then loss of heterozygosity, is required for high-level echinocandin resistance in C. albicans. Both alleles of GSC1 contribute equally and independently to beta-1,3-glucan synthase activity.
机译:目的:确定在实验室产生的和临床的白色念珠菌分离株中,GSC1(FKS1)杂合和纯合突变引起的中,高水平棘皮菌素抗性的机制。方法:比较了GSC1,GSL1(FKS3)和RHO1的全部开放阅读框的DNA序列,这可能与米卡芬净易感菌株的β-1,3-葡聚糖合酶和耐药的临床分离株有关。通过选择米卡芬净抗性而分离出的自发杂合突变体,以及一组由棘皮菌素敏感和抗性等位基因组合而成的实验室产生的纯合和杂合突变体,或缺失了个别GSC1等位基因的突变体,用于比较棘皮菌素的水平抗性和葡聚糖合酶活性的抑制。结果:DNA序列分析在临床分离株的GSC1的两个等位基因中鉴定出一个突变S645P。由于等位基因变异,GSL1具有两个纯合氨基酸变化和五个非同义核苷酸多态性。菌株之间Rho1p的预测氨基酸序列是保守的。杂合(S645 / S645F)和纯合(S645F / S645F)突变的重建表明,纯合突变比杂合突变(1 mg / L)赋予更高的米卡芬净抗性(4 mg / L)。将杂合突变体暴露于米卡芬净导致杂合性丧失。对β-1,3-葡聚糖合酶活性的动力学分析表明,纯合子和杂合子突变使棘皮菌素敏感性分布与其MIC值相关。结论:白色念珠菌对棘皮菌素具有高水平的抗性,需要在一个等位基因中发生突变,然后丧失杂合性,从而导致GSC1发生纯合性热点突变。 GSC1的两个等位基因均相同且独立地参与β-1,3-葡聚糖合酶的活性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号